Which company successfully developed the first FDA-approved CRISPR-based therapy for human genetic disease treatment in 2023?

CRISPR gene editing technology represents one of the most significant product innovations in scientific research and medicine this century. This powerful tool has transformed how scientists can modify DNA with unprecedented precision, opening new possibilities for treating genetic diseases, enhancing crop resilience, and advancing biological research. Test your knowledge about this groundbreaking scientific product that's changing the future of healthcare and biotechnology.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

CRISPR Therapeutics and Vertex Pharmaceuticals (for sickle cell disease)
Editas Medicine and Allergan (for inherited retinal disease)
Intellia Therapeutics and Regeneron (for transthyretin amyloidosis)
Beam Therapeutics and Pfizer (for beta thalassemia)